GlucoMe’s Decision Support System (“DSS”) personalizes treatment recommendations ensuring optimal oral drug intensification (2nd and 3rd line) for type 2 diabetes mellitus patients.

GlucoMe, innovating and marketing a comprehensive digital diabetes platform, announced today that it will participate in the Startup Creasphere Batch 2 program by Roche and Plug and Play, to explore a possible collaboration to advance its comprehensive digital diabetes platform.

Digital diabetes solution provider, GlucoMe, announced today that it is exploring the expansion of its partnership with Merck KGaA, Darmstadt, Germany.

This follows a successful joint pilot in several Vietnam hospitals, facilitated by a third party.